Mounjaro (Tirzepatide) 2.5 mg injection is an anti-diabetic medicine used to improve blood sugar control in adults with type 2 diabetes. It also supports weight loss in overweight or obese adults when combined with a healthy diet and regular exercise. Buy diabetes medications online for safe and convenient care
Mounjaro 2.5mg is an injectable form of tirzepatide, a dual GIP and GLP-1 receptor agonist. It is generally used, alongside diet and exercise, to help improve blood sugar control in adults with type 2 diabetes. The 2.5mg strength is typically used as a starting dose when beginning treatment.
Mounjaro 2.5mg contains tirzepatide, a once-weekly injectable medicine belonging to a class known as GIP/GLP-1 receptor agonists. It works by acting on two natural gut hormone pathways involved in blood sugar regulation.
This strength is generally used as the initial dose when starting treatment, allowing the body to adjust before the dose is gradually increased, where appropriate, under medical supervision. Mounjaro is not a form of insulin.
Mounjaro 2.5mg may be prescribed to:
Help improve blood glucose (blood sugar) control in adults with type 2 diabetes, used alongside diet and exercise
The appropriate treatment and dose should be determined by a healthcare professional based on individual health needs.
Mounjaro works by mimicking two natural hormones, GIP and GLP-1, that the gut releases after eating. By activating both of these receptors, it helps the pancreas release insulin when blood sugar is high and reduces the amount of glucagon (a hormone that raises blood sugar) released by the body. It also slows down how quickly the stomach empties, which can affect appetite.
These combined effects generally support better blood sugar control over time. Noticeable changes in blood sugar levels typically develop gradually over the first weeks of treatment, though individual response can vary.
Take Mounjaro exactly as prescribed by your healthcare professional.
Usually injected once weekly, on the same day each week
Can generally be taken with or without food
May be taken at any time of day
Injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm, rotating the injection site with each dose
Do not stop or change your dose without speaking to your healthcare professional first, even if you feel well
Missed dose: If a dose is missed, it should generally be administered as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, the missed dose should be skipped and the next dose taken on the regularly scheduled day. Speak with your pharmacist or doctor if you are unsure what to do after a missed dose.
Before starting Mounjaro, tell your doctor or pharmacist about your full medical history and all medicines, supplements, and herbal products you use.
Caution may be needed in people with:
A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
A history of pancreatitis
Diabetic retinopathy
Gallbladder disease
Severe gastrointestinal disease
Kidney problems, particularly if experiencing dehydration
Known hypersensitivity to tirzepatide or any ingredient in Mounjaro
Mounjaro may interact with other medicines, particularly:
Insulin or sulfonylureas (may increase the risk of low blood sugar)
Oral contraceptives (absorption may be affected; an alternative or additional contraceptive method may be recommended)
Other medicines taken by mouth, as Mounjaro can slow stomach emptying and affect how they are absorbed
Always check for possible interactions with a doctor or pharmacist before starting or combining medicines.
Mounjaro is generally not recommended during pregnancy, as animal studies suggest a potential risk to the developing baby and there is limited data in humans. Anyone who is pregnant, planning a pregnancy, or breastfeeding should speak with their doctor or pharmacist before using this medicine, as recommendations may vary depending on individual circumstances and local guidance.
Like all medicines, Mounjaro can cause side effects, although not everyone experiences them.
Common side effects may include:
Nausea
Diarrhoea
Decreased appetite
Vomiting
Constipation
Indigestion (dyspepsia)
Abdominal pain
Seek prompt medical attention for symptoms such as severe or persistent abdominal pain (which may indicate pancreatitis), signs of a serious allergic reaction (such as swelling of the face, lips, or throat, or difficulty breathing), or symptoms of very low blood sugar such as confusion, shakiness, or sweating.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Mounjaro according to the instructions shown on the original product packaging.
Keep in the original packaging to protect from light
Keep out of reach and sight of children
Do not use after the expiry date shown on the packaging
It's the starting dose used to begin tirzepatide treatment for type 2 diabetes, allowing the body to adjust before moving to higher, glycaemic-control doses.
Not significantly — this strength is intended for treatment initiation rather than glycaemic control, with effects becoming more meaningful at higher maintenance doses.
It's typically used for around four weeks before your doctor considers increasing to the next dose, depending on tolerance.
It's injected once weekly, ideally on the same day each week, at any time of day, with or without food.
If it's within 4 days of the missed dose, take it as soon as possible; if more than 4 days have passed, skip it and take the next dose on your regular scheduled day.
It's injected subcutaneously into the abdomen, thigh, or upper arm, rotating sites with each injection.
